Prostate Cancer - Results from #20860

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer - Abstract April 4, 2014

Automatic CT simulation optimization for radiation therapy: A general strategy - Abstract April 4, 2014

Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array - Abstract April 4, 2014

Modified Gleason grade of prostatic adenocarcinomas detected in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial - Abstract April 4, 2014

Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU) - A multi-center retrospective study - Abstract April 4, 2014

Impact of race in using PSA velocity to predict for prostate cancer - Abstract April 4, 2014

Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest Gleason score ≥ 7 - Abstract April 4, 2014

Effect of change to flutamide for prostate cancer patient who developed breast pain during bicalutamide treatment (BIP-F study) - Abstract April 4, 2014

Segmentation of pelvic structures for planning CT using a geometrical shape model tuned by a multi-scale edge detector - Abstract April 3, 2014

Prostate cancer in Asian men - Abstract April 3, 2014

Is there a relationship between acute coronary syndrome and prostate specific antigen level? - Abstract April 3, 2014

Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy - Abstract April 3, 2014

Development and evaluation of an articulated registration algorithm for human skeleton registration - Abstract April 3, 2014

Astellas announces European regulatory submission For XTANDI® (enzalutamide) capsules For chemotherapy-naive metastatic prostate cancer April 3, 2014

Biologically effective dose and definitive radiation treatment for localized prostate cancer: Treatment gaps do affect the risk of biochemical failure - Abstract April 3, 2014

Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: Results of CALGB 90202 (Alliance) - Abstract April 3, 2014

Clinical performance of serum isoform [-2]proPSA (p2PSA) and its derivatives, namely %p2PSA and PHI (Prostate Health Index) in men younger than 60 years of age: Results from a multicentric European study - Abstract April 2, 2014

Targeted prostate biopsy: Value of multiparametric magnetic resonance imaging in detection of localized cancer - Abstract April 2, 2014

Radical prostatectomy or radiotherapy in high-risk prostate cancer: A systematic review and metaanalysis - Abstract April 2, 2014

The role of transperineal template prostate biopsies in prostate cancer diagnosis in biopsy naïve men with PSA less than 20 ng ml-1 - Abstract April 2, 2014

Page 1044 of 1436